Gamma Valerolactone Market Size(US$)

CAGR 2025-2031
-0.3%
Market Size,2031
USD 725
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Global Gamma Valerolactone (CAS 108-29-2) key players include Anhui Hyea Aromas, Dideu Industries, Kunshan Qiandeng Baihua, etc. Global top three manufacturers hold a share over 75%.
China is the largest market, with a share over 85%, followed by Japan, and USA, both have a share about 10 percent.
In terms of product, Food Grade is the largest segment, with a share nearly 75%. And in terms of application, the largest application is Food Flavors, followed by Monomer Intermediate, Solvents, etc.
This report aims to provide a comprehensive presentation of the global market for Gamma Valerolactone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gamma Valerolactone by region & country, by Type, and by Application.
The Gamma Valerolactone market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gamma Valerolactone.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gamma Valerolactone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Gamma Valerolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Gamma Valerolactone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Gamma Valerolactone Product Introduction
1.2 Global Gamma Valerolactone Market Size Forecast
1.2.1 Global Gamma Valerolactone Sales Value (2020-2031)
1.2.2 Global Gamma Valerolactone Sales Volume (2020-2031)
1.2.3 Global Gamma Valerolactone Sales Price (2020-2031)
1.3 Gamma Valerolactone Market Trends & Drivers
1.3.1 Gamma Valerolactone Industry Trends
1.3.2 Gamma Valerolactone Market Drivers & Opportunity
1.3.3 Gamma Valerolactone Market Challenges
1.3.4 Gamma Valerolactone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gamma Valerolactone Players Revenue Ranking (2024)
2.2 Global Gamma Valerolactone Revenue by Company (2020-2025)
2.3 Global Gamma Valerolactone Players Sales Volume Ranking (2024)
2.4 Global Gamma Valerolactone Sales Volume by Company Players (2020-2025)
2.5 Global Gamma Valerolactone Average Price by Company (2020-2025)
2.6 Key Manufacturers Gamma Valerolactone Manufacturing Base and Headquarters
2.7 Key Manufacturers Gamma Valerolactone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Gamma Valerolactone
2.9 Gamma Valerolactone Market Competitive Analysis
2.9.1 Gamma Valerolactone Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Gamma Valerolactone Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gamma Valerolactone as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Food Grade
3.1.2 Industrial Grade
3.2 Global Gamma Valerolactone Sales Value by Type
3.2.1 Global Gamma Valerolactone Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Gamma Valerolactone Sales Value, by Type (2020-2031)
3.2.3 Global Gamma Valerolactone Sales Value, by Type (%) (2020-2031)
3.3 Global Gamma Valerolactone Sales Volume by Type
3.3.1 Global Gamma Valerolactone Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Gamma Valerolactone Sales Volume, by Type (2020-2031)
3.3.3 Global Gamma Valerolactone Sales Volume, by Type (%) (2020-2031)
3.4 Global Gamma Valerolactone Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food Flavors
4.1.2 Solvent
4.1.3 Monomer Intermediate
4.1.4 Others
4.2 Global Gamma Valerolactone Sales Value by Application
4.2.1 Global Gamma Valerolactone Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Gamma Valerolactone Sales Value, by Application (2020-2031)
4.2.3 Global Gamma Valerolactone Sales Value, by Application (%) (2020-2031)
4.3 Global Gamma Valerolactone Sales Volume by Application
4.3.1 Global Gamma Valerolactone Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Gamma Valerolactone Sales Volume, by Application (2020-2031)
4.3.3 Global Gamma Valerolactone Sales Volume, by Application (%) (2020-2031)
4.4 Global Gamma Valerolactone Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Gamma Valerolactone Sales Value by Region
5.1.1 Global Gamma Valerolactone Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Gamma Valerolactone Sales Value by Region (2020-2025)
5.1.3 Global Gamma Valerolactone Sales Value by Region (2026-2031)
5.1.4 Global Gamma Valerolactone Sales Value by Region (%), (2020-2031)
5.2 Global Gamma Valerolactone Sales Volume by Region
5.2.1 Global Gamma Valerolactone Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Gamma Valerolactone Sales Volume by Region (2020-2025)
5.2.3 Global Gamma Valerolactone Sales Volume by Region (2026-2031)
5.2.4 Global Gamma Valerolactone Sales Volume by Region (%), (2020-2031)
5.3 Global Gamma Valerolactone Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Gamma Valerolactone Sales Value, 2020-2031
5.4.2 North America Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Gamma Valerolactone Sales Value, 2020-2031
5.5.2 Europe Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Gamma Valerolactone Sales Value, 2020-2031
5.6.2 Asia Pacific Gamma Valerolactone Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Gamma Valerolactone Sales Value, 2020-2031
5.7.2 South America Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Gamma Valerolactone Sales Value, 2020-2031
5.8.2 Middle East & Africa Gamma Valerolactone Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gamma Valerolactone Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Gamma Valerolactone Sales Value
6.2.1 Key Countries/Regions Gamma Valerolactone Sales Value, 2020-2031
6.2.2 Key Countries/Regions Gamma Valerolactone Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Gamma Valerolactone Sales Value, 2020-2031
6.3.2 United States Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Gamma Valerolactone Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Gamma Valerolactone Sales Value, 2020-2031
6.4.2 Europe Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Gamma Valerolactone Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Gamma Valerolactone Sales Value, 2020-2031
6.5.2 China Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.5.3 China Gamma Valerolactone Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Gamma Valerolactone Sales Value, 2020-2031
6.6.2 Japan Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Gamma Valerolactone Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Gamma Valerolactone Sales Value, 2020-2031
6.7.2 South Korea Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Gamma Valerolactone Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Gamma Valerolactone Sales Value, 2020-2031
6.8.2 Southeast Asia Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Gamma Valerolactone Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Gamma Valerolactone Sales Value, 2020-2031
6.9.2 India Gamma Valerolactone Sales Value by Type (%), 2024 VS 2031
6.9.3 India Gamma Valerolactone Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Anhui Hyea Aromas
7.1.1 Anhui Hyea Aromas Company Information
7.1.2 Anhui Hyea Aromas Introduction and Business Overview
7.1.3 Anhui Hyea Aromas Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Anhui Hyea Aromas Gamma Valerolactone Product Offerings
7.1.5 Anhui Hyea Aromas Recent Development
7.2 Dideu Industries
7.2.1 Dideu Industries Company Information
7.2.2 Dideu Industries Introduction and Business Overview
7.2.3 Dideu Industries Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Dideu Industries Gamma Valerolactone Product Offerings
7.2.5 Dideu Industries Recent Development
7.3 Kunshan Qiandeng Baihua
7.3.1 Kunshan Qiandeng Baihua Company Information
7.3.2 Kunshan Qiandeng Baihua Introduction and Business Overview
7.3.3 Kunshan Qiandeng Baihua Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Kunshan Qiandeng Baihua Gamma Valerolactone Product Offerings
7.3.5 Kunshan Qiandeng Baihua Recent Development
7.4 Zhongyue Aroma
7.4.1 Zhongyue Aroma Company Information
7.4.2 Zhongyue Aroma Introduction and Business Overview
7.4.3 Zhongyue Aroma Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Zhongyue Aroma Gamma Valerolactone Product Offerings
7.4.5 Zhongyue Aroma Recent Development
7.5 Soda Aromatic
7.5.1 Soda Aromatic Company Information
7.5.2 Soda Aromatic Introduction and Business Overview
7.5.3 Soda Aromatic Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Soda Aromatic Gamma Valerolactone Product Offerings
7.5.5 Soda Aromatic Recent Development
7.6 Inoue Perfumery MFG
7.6.1 Inoue Perfumery MFG Company Information
7.6.2 Inoue Perfumery MFG Introduction and Business Overview
7.6.3 Inoue Perfumery MFG Gamma Valerolactone Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Inoue Perfumery MFG Gamma Valerolactone Product Offerings
7.6.5 Inoue Perfumery MFG Recent Development
8 Industry Chain Analysis
8.1 Gamma Valerolactone Industrial Chain
8.2 Gamma Valerolactone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gamma Valerolactone Sales Model
8.5.2 Sales Channel
8.5.3 Gamma Valerolactone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published Date: 2025-09-12
Pages: 94
USD 2900.00
(Single User License)
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-09-12
Pages: 78
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-12
Pages: 136
USD 4900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 109
USD 3950.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 135
USD 3950.00
(Single User License)
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 133
USD 2900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-08-07
Pages: 128
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-07
Pages: 141
USD 4900.00
(Single User License)
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
Published: 2024-04-17
Pages: 151
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published: 2025-09-12
Pages: 94
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-09-12
Pages: 78
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-12
Pages: 136
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 109
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 135
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 133
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-08-07
Pages: 128
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-07
Pages: 141
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report